NCT00528996 · Interventional trial
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
Overall registry status Completed
Phase 2
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- 1205.14.003 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory